VaxForm LLC
VaxForm LLC is dedicated to developing innovative vaccine solutions, including oral COVID-19 vaccines, through research, development, and contract services. Their mission focuses on advancing vaccine technology with a strong emphasis on thermostability and mucosal delivery platforms.
Industries
Nr. of Employees
small (1-50)
VaxForm LLC
Products
Oral SARS-CoV-2 vaccine candidate
An orally administered, thermostable vaccine candidate targeting SARS-CoV-2 developed using an oral/mucosal delivery platform and stabilized formulation approaches.
Oral DTaP vaccine candidate
Development of an orally administered diphtheria–tetanus–pertussis vaccine using an oral delivery platform and adjuvant incorporation to produce a thermostable oral formulation.
Vaccine candidate targeting Streptococcus pyogenes
Recombinant fusion protein vaccine candidate aimed at inducing neutralizing antibodies against Streptococcus pyogenes with demonstrated preclinical immunogenicity and stability.
Oral SARS-CoV-2 vaccine candidate
An orally administered, thermostable vaccine candidate targeting SARS-CoV-2 developed using an oral/mucosal delivery platform and stabilized formulation approaches.
Oral DTaP vaccine candidate
Development of an orally administered diphtheria–tetanus–pertussis vaccine using an oral delivery platform and adjuvant incorporation to produce a thermostable oral formulation.
Vaccine candidate targeting Streptococcus pyogenes
Recombinant fusion protein vaccine candidate aimed at inducing neutralizing antibodies against Streptococcus pyogenes with demonstrated preclinical immunogenicity and stability.
Services
Consulting and contract development for vaccine products
Contract services including small-scale antigen fermentation and purification, formulation development with adjuvantation and stabilization, assay development, and small-scale final drug product filling.
Consulting and contract development for vaccine products
Contract services including small-scale antigen fermentation and purification, formulation development with adjuvantation and stabilization, assay development, and small-scale final drug product filling.
Expertise Areas
- Vaccine formulation and stabilization
- Oral and mucosal vaccine delivery
- Adjuvant formulation and production
- Small-scale antigen production and fill–finish
Key Technologies
- Thermostable vaccine formulation
- Oral/mucosal delivery platforms
- mRNA lipid nanoparticle stabilization
- Recombinant protein subunit vaccine development